Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated TCM and Western Therapy for Small Artery Occlusive Ischemic Stroke
ChiCTR2600124500Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Henan University of Chinese Medicine
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Zhishe Tongluo Capsules in ischemic stroke (2 arms), sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoint: Composite vascular events within 1 year. Planned start May 2026; status: not yet recruiting.
02
Drugs
Zhishe Tongluo Capsules
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2600124500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124500.